Ratiopharm Pharmaceuticals

Ratiopharm is one of Germany’s most recognized pharmaceutical brands, specializing in the production of high-quality generic medications. Founded in 1974 in Ulm, Germany, by Adolf Merckle, it was the first company in the country to focus exclusively on generics, aiming to provide affordable healthcare alternatives to expensive brand-name drugs.

Today, the brand operates as a major component of the global pharmaceutical landscape. While its roots and primary manufacturing hubs remain in Germany—specifically in Blaubeuren and Ulm—its supply chain and production facilities extend across multiple international sites as part of a global network. This ensures a broad distribution of essential medicines ranging from over-the-counter pain relievers to specialized prescription treatments.

In 2010, Ratiopharm was acquired by Teva Pharmaceutical Industries Ltd., an Israeli multinational that is currently the world's largest generic drug manufacturer. Under Teva's ownership, Ratiopharm has maintained its strong brand identity in Europe while benefiting from the extensive research, development, and logistical capabilities of its parent company. The brand remains synonymous with cost-effective and reliable medicine for both patients and healthcare providers.